SEC Form 4 · accession 0001447348-15-000041
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheldon Hirt
Officer — Executive VP & General Counsel
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 1:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $8.56 | Aug 3, 2015 | A | 125,000 | A | — | Aug 3, 2025 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1The stock options become exercisable in five equal installments, commencing one year from the grant date.